| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | etonogestrel (Nexplanon®) |
| Formulation | 68 mg implant |
| Reference number | 766 |
| Indication | Contraception where safety and efficacy have been established in women between 18 and 40 years of age |
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 16/08/2010 |